header (8)

CME-Program Available

When Anti-PD1 Therapy Fails, Could Oncolytic Immunotherapy Impact Outcomes in Advanced Melanoma?

ACCESS THE PROGRAM

Europe Map

Ressources pour les patients et les médecins Ressourcen für Patienten und Ärzte Risorse per pazienti e medici Updated in French, German, and Italian

Tebentafusp resources for patients and providers

Health Care Provider Resources for Optimizing Immunotherapy

These reflect management strategies for immune-related adverse event grading and management.

Care Step Pathways

Step-by-step assessment and management guides for notable AEs associated with newer therapies

Provider Toolkit

Online and downloadable quick and easy resources to advance the care of immunotherapy patients

Printable Patient Materials

Educate and engage patients with information on specific therapies

HCP Videos

Video Portal: short side-effect management snippets

Facebook Q&A Community

Share challenges, insights, and solutions with other oncology providers in our Facebook community

Education

Stay up to date on immunotherapy patient care with free online education modules and events

AIM with Immunotherapy
JCO OP Supplement

JCO Oncology Practice uses cases to illustrate optimal multidisciplinary management of irAEs

Regional Meetings

Learn about immunotherapy from colleagues in your region

Resources by Tumor Type

View all of the patient and provider resources by tumor type

Meet the AWI
Leadership Board

Experts empowering providers with tools to improve patient outcomes with immunotherapy

News

Get the latest news on immunotherapy

Copyright ©2022- - AIM with Immunotherapy. All rights reserved.